May 5, 2022
Pediatric Drug Therapy 2020 | Generic Drugs and Drug Pricing
Pediatric Drug Therapy 2020
Generic Drugs and Drug Pricing
Daniel E. Leifer, MD
Resident Physician in Dermatology and Board-Certified Pediatrician, Division of Dermatology, UW
For pediatric nurse practitioners, family nurse practitioners, physician assistants, clinical nurse specialists, nurses, respiratory therapists, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Describe how a drug is licensed, what the difference is between an NDA and an ANDA, and the
intellectual property considerations that underlie the distinction.
- Enumerate the key players (PBMs, pharmaceutical companies, regulators, etc.) that affect drug
- Propose regulatory frameworks that would make prescription medications more accessible.